KALA BIO, Inc. (KALA)
$0.26-7.14%Close
SELLCRISIS · day 38
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6M
- Beta
- -2.41
- P/E (TTM)
- -0.00
- Short % float
- 7.22%
- Days to cover
- 1.0
- SI change
- +205.1%
- 1W
- -27.78%
- 1M
- -51.85%
- vs SPY 1W
- -27.64%
- vs SPY 1M
- -54.36%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on KALA?
- LOPJLB’s latest quantitative signal on KALA BIO, Inc. (KALA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is KALA in?
- KALA BIO, Inc. (KALA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does KALA BIO, Inc. (KALA) do?
- Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-foun…